Finasteride Manufacturer Copay Program: How to Cut Your Costs in 2026

Why a "Manufacturer Copay Program" for Finasteride Is Hard to Find

The short answer is that finasteride lost patent exclusivity in 2006 for the 5 mg dose (Proscar) and in 2013 for the 1 mg dose (Propecia), so Merck no longer funds an active copay card for either branded version [1]. Copay assistance programs exist primarily to offset the price gap between a branded drug and its generic equivalent. Once that gap disappears, the economic rationale for the program vanishes with it.

That does not mean you are stuck paying full price. Finasteride is one of the least expensive prescription medications in the United States. A 2023 GoodRx market analysis placed generic finasteride 1 mg among the top 10 most affordable generics dispensed nationally, with median cash prices between $4 and $12 for a 30-day supply [2]. The drug ranks on the World Health Organization's Model List of Essential Medicines, a designation that encourages broad generic manufacturing and price competition [3].

Patients still taking branded Proscar 5 mg for benign prostatic hyperplasia (BPH) may qualify for the Merck Patient Assistance Program, which provides free medication to uninsured individuals earning below 400% of the federal poverty level [4]. The application requires proof of income, a valid prescription, and a prescriber signature. Processing takes two to four weeks.

Generic Finasteride Pricing: What You Should Actually Expect to Pay

Most patients filling generic finasteride 1 mg at a U.S. retail pharmacy will pay between $3 and $15 out of pocket, even without insurance. The price depends on the pharmacy chain, your zip code, and whether you present a discount card. Costco and Walmart often stock 30 tablets for under $5 at their published cash-pay pricing schedules [5].

The price floor has dropped substantially since 2020. An analysis of National Average Drug Acquisition Cost (NADAC) data published by the Centers for Medicare & Medicaid Services (CMS) showed that the per-unit wholesale acquisition cost for finasteride 1 mg fell from $0.19 in 2020 to $0.08 in 2024 [6]. That translates to a raw ingredient cost of roughly $2.40 for a 30-day supply before any pharmacy markup.

If you carry commercial insurance, expect to pay $0 to $10 per fill. The American Academy of Family Physicians notes that generic finasteride sits on Tier 1 of virtually every commercial formulary in the country, which means the lowest possible copay tier [7]. High-deductible health plans (HDHPs) are the one exception. Under an HDHP, you pay the full negotiated rate until your deductible is met, but even then the negotiated rate for finasteride rarely exceeds $15.

Insurance Coverage for Finasteride: BPH vs. Hair Loss

Here is where payers draw a line. Finasteride carries two FDA-approved indications: treatment of BPH (as Proscar 5 mg) and treatment of male androgenetic alopecia (as Propecia 1 mg) [8]. Insurance plans almost universally cover the BPH indication because the American Urological Association lists finasteride as a first-line medical therapy for moderate-to-severe lower urinary tract symptoms secondary to BPH [9].

Coverage for hair loss is different. Many commercial plans classify androgenetic alopecia as a cosmetic condition and exclude finasteride prescribed for that purpose. A 2022 Kaiser Family Foundation employer benefit survey found that 68% of large-employer plans explicitly excluded "cosmetic pharmaceuticals," a category that typically includes hair-loss drugs [10]. If your plan denies coverage for the 1 mg hair-loss indication, you have three practical options.

First, ask your prescriber to document a medical rationale beyond cosmetics. Androgenetic alopecia is classified as ICD-10 code L64.9, and some plans will approve coverage if the prescriber notes psychological distress or a secondary diagnosis. Second, use a pharmacy discount coupon (discussed below) and pay cash. Third, request the 5 mg tablet prescribed for BPH if you also have documented lower urinary tract symptoms, then split the tablet. Pill splitting is a well-established cost-reduction strategy recognized by the VA system and multiple pharmacy benefit managers [11].

A one-sentence caution: tablet splitting should only be done with scored tablets and a proper pill splitter, and your prescriber should explicitly approve the practice.

How Pharmacy Discount Coupons Work for Finasteride

Pharmacy discount platforms (GoodRx, RxSaver, SingleCare, Amazon Pharmacy, and Cost Plus Drugs) negotiate group purchasing rates with pharmacies and pass the savings to consumers as a printed or digital coupon. These are not insurance. They function as a separate cash-pay rate.

For finasteride 1 mg (30 tablets), GoodRx lists prices as low as $3.00 at select pharmacies including Costco, Kroger, and Walmart [2]. SingleCare shows comparable pricing at CVS and Walgreens. Mark Cuban's Cost Plus Drugs pharmacy prices finasteride 1 mg at $3.60 for 30 tablets with a flat $5 shipping fee for mail orders, bringing the effective cost to $8.60 delivered [12].

You cannot combine a discount coupon with insurance. Choose whichever option yields the lower price at checkout. Pharmacists can run both and tell you which saves more. This is standard practice.

For the 90-day mail-order channel, Amazon Pharmacy prices generic finasteride 1 mg at $6 to $9 for Prime members (90-tablet supply), which works out to $2 to $3 per month [13]. That is among the lowest per-unit costs available without a formal patient assistance program.

Medicare and Medicaid Coverage for Finasteride

Generic finasteride is covered under Medicare Part D. Because it is a Tier 1 generic on most Part D formularies, your copay will typically fall between $0 and $11 per month depending on your plan [14]. The Medicare Plan Finder tool at medicare.gov lets you search formulary coverage by drug name and zip code.

Under the Inflation Reduction Act provisions that took effect in 2025, Medicare Part D out-of-pocket costs are capped at $2,000 per year across all covered drugs [15]. Finasteride alone will never come close to that cap, but the provision matters if you take multiple medications.

Medicaid coverage varies by state. All 50 state Medicaid programs cover finasteride for BPH, but coverage for the hair-loss indication is inconsistent. States with open formularies (no prior authorization for generics) tend to cover both indications. States with closed or restricted formularies may require a prior authorization for the 1 mg dose [16].

The Veterans Health Administration covers finasteride on the VA National Formulary for both BPH and alopecia, dispensed through VA pharmacies at no cost to veterans with a service-connected condition or those who meet copay-exemption criteria [17]. Non-exempt veterans pay a flat $5 copay for a 30-day supply.

Compounded Topical Finasteride: Cost and Coverage Gaps

Topical finasteride (typically 0.1% to 0.25% in a minoxidil base) has gained popularity as an alternative to oral dosing. A 2022 randomized trial in the Journal of the American Academy of Dermatology (N=458) showed that topical finasteride 0.25% applied once daily reduced hair-loss progression comparably to oral finasteride 1 mg over 24 weeks, with lower serum DHT suppression (34% vs. 55.6%) [18].

Compounded topical finasteride costs approximately $30 to $60 per month from compounding pharmacies, with an average around $45. Insurance virtually never covers compounded medications. No manufacturer copay card exists for compounded products because they are pharmacy-prepared, not manufactured by a single drug company.

Telehealth platforms (Hims, Keeps, Ro) sell proprietary topical finasteride formulations for $30 to $75 per month on subscription plans. These prices include the prescriber consultation fee in most cases. The FDA has not approved a commercial topical finasteride product as of May 2026, so all topical formulations are either compounded under 503A/503B pharmacy rules or sold as unapproved products [19].

Patient Assistance Programs Beyond the Manufacturer

Several nonprofit and pharmacy-based programs can reduce finasteride costs for uninsured or underinsured patients.

NeedyMeds maintains a database of generic drug discount programs and state pharmaceutical assistance programs (SPAPs) that may apply to finasteride [20]. Seventeen states operate SPAPs that supplement Medicare Part D coverage, and some extend to non-Medicare patients.

RxAssist is a similar directory maintained by the National Council on Aging. Both resources are free to search and updated monthly.

340B Drug Pricing Program participants (federally qualified health centers, Ryan White clinics, critical access hospitals) purchase finasteride at a steep discount and can pass savings to qualifying patients. If you receive care at a 340B-covered entity, ask the pharmacy whether 340B pricing applies to your prescription [21]. The Health Resources and Services Administration (HRSA) maintains a public database of covered entities at 340bopais.hrsa.gov.

Walmart $4 Generic Program still includes finasteride 5 mg (30 tablets) at $4 and finasteride 1 mg (30 tablets) at $4 to $9 depending on location [5]. Sam's Club and Costco offer comparable pricing to members and, in Costco's case, to non-members at the pharmacy counter.

Step-by-Step: Getting the Lowest Price on Finasteride

The optimal strategy depends on your insurance status.

If you have commercial insurance: Fill at your plan's preferred pharmacy. Generic finasteride should appear on Tier 1. Confirm that the prior authorization status is "not required" for your indication. If your copay exceeds $10, compare it to the GoodRx or SingleCare cash price and use whichever is lower.

If you have Medicare Part D: Use the Medicare Plan Finder to verify formulary placement. Fill through your plan's preferred mail-order pharmacy for the 90-day supply discount. Expected cost: $0 to $11 per 30 days.

If you are uninsured: Check Cost Plus Drugs ($3.60 for 30 tablets plus shipping) or Costco (often under $5 without membership for pharmacy purchases). Present a GoodRx or SingleCare coupon at checkout. For the 5 mg BPH dose, Walmart's $4 generic tier applies.

If you are a veteran: Request finasteride through the VA pharmacy system. Cost is $0 for service-connected conditions or $5 per 30-day fill otherwise.

If your income is below 400% FPL and you need branded Proscar: Apply to the Merck Patient Assistance Program at merckhelps.com. Turnaround is two to four weeks [4].

Is Finasteride Worth the Cost? Clinical Effectiveness Data

For BPH, the Proscar Long-Term Efficacy and Safety Study (PLESS, N=3,040) demonstrated that finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for surgery by 55% over four years compared to placebo [22]. The Medical Therapy of Prostatic Symptoms (MTOPS) trial (N=3,047) confirmed that finasteride combined with doxazosin reduced clinical BPH progression by 66% versus placebo over 4.5 years [23].

For androgenetic alopecia, a key phase III trial (N=1,553) showed that finasteride 1 mg daily increased hair count by a mean of 107 hairs per square inch at the vertex over 24 months versus a loss of 30 hairs per square inch in the placebo group [24]. Treatment response plateaus around 12 months and is maintained for at least five years based on extension-study data.

The most commonly reported adverse effects are decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7% placebo), and decreased ejaculate volume (0.8% vs. 0.4% placebo) based on pooled phase III data [8]. These effects resolved in most men who discontinued therapy and in 58% of men who continued.

A cost-effectiveness analysis published in JAMA Dermatology estimated that generic finasteride 1 mg for male pattern hair loss costs approximately $47 per quality-adjusted life year (QALY) gained, making it one of the most cost-effective dermatologic interventions available [25].

At current generic prices, a full year of finasteride 1 mg treatment costs between $36 and $120 out of pocket without insurance. With insurance or a discount coupon, annual cost drops to $0 to $60. For a drug that has over 30 years of safety data and well-characterized efficacy across two indications, the cost-to-benefit ratio remains exceptionally favorable.